FDA Data Science Fellowship - Bioinformatics and AI​/Machine Learning

How To Apply

To submit your application, scroll to the bottom of this opportunity and click APPLY.

• An application
• Transcripts –  for detailed information about acceptable transcripts
• A current resume/CV, including academic history, employment history, relevant experiences, and publication list
• One educational or professional recommendation

All documents must be in English or include an official English translation.

Send an email to ORISE.FDA.CBER. Please include the reference code for this opportunity in your email.

U.S. Food and Drug Administration (FDA)

FDA-CBER-

5/29/2026 3:00:00 PM Eastern Time Zone

Applications will be reviewed on a rolling-basis.

Office of Biostatistics and Pharmacovigilance (OBPV) at the Center for Biologics Evaluation and Research (CBER), FDA in Silver Spring, Maryland.

The fellow will contribute to the development of novel scientific, bioinformatics, and AI/machine learning algorithms, as well as the adaptation and optimization of existing tools. This research aligns with CBER’s efforts to enhance the development, operations, and management of FDA’s High-performance Integrated Virtual Environment (HIVE) infrastructure and scientific computing environment.

The opportunity involves building and improving applications that compute, analyze, and interpret biological and scientific data, including large-scale omics datasets, within high-performance computing (HPC) environments.

• Develop and implement novel scientific, bioinformatics, and AI/ML algorithms
• Optimize and adapt existing analytical tools for performance and scalability
• Suggest and implement new software solutions and computational tools
• Maintain, support, and test applications for bugs, redundancies, and security issues
• Standardize and automate application-level processes
• Maintain and improve components of the bioinformatics and AI-focused HPC environment
• Gain experience working with large-scale biological datasets, including genomics, transcriptomics (bulk and single-cell), and proteomics data

Luis Santana-Quintero (luis.santana-quintero.gov). If you have questions about the nature of the research, please contact the mentor.

2026. Start date is flexible and will depend on a variety of factors.

The appointment will initially be for one year, but may be renewed upon recommendation of FDA and is contingent on the availability of funds.

The appointment is full time.

The participant will receive a monthly stipend commensurate with educational level and experience.

This opportunity is available to U.S. citizens, Lawful Permanent Residents (LPR), and foreign nationals. Non-U.S. citizen applicants should refer to the Guidelines for Non-U.S. Citizens Details page of the program website for information about the valid immigration statuses that are acceptable for program participation.

This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and Education, was established through an interagency agreement between DOE and FDA. The participant will receive a monthly stipend commensurate with educational level and experience. Proof of health insurance is required for participation in this program. Participants do not become employees of FDA, DOE or the program administrator, and there are no employment-related benefits.

Completion of a successful background investigation by the Office of Personnel Management is required for an applicant to be onboarded  can complete a background investigation only for individuals, including non-US Citizens, who have resided in the US for a total of three of the past five years.

If an ORISE Fellow, to include their spouse and minor children, reports what is identified as a Significantly Regulated Organization (SRO) or prohibited investment fund financial interest in any amount, or a relationship with an SRO, except for spousal employment with an SRO, and…